News

Ideas That Generate Results

The R&D spending of drug companies could increase to the tune of 25-50% due to the incentives offered by the Indian government in its budget. This will propel the growth of Indian Clinical trial market. According to our new research on the sector titled "Booming Clinical Trials Market in India", the clinical trial outsourcing market in India is forecast to grow at a CAGR of around 31% during 2010-2012.

The key findings of the report show that the country is poised to become one of the leading destinations for conducting clinical trials, owing to a huge patient pool with both chronic and infectious diseases, high cost savings and easy recruitment of patients. Moreover, the changing regulatory environment and introduction of patent regime has also given a significant boost to the Indian clinical trial market. The report analyzes the regulatory environment of India which is the most important factor for the development of an industry. It also provides some valuable suggestions which can be useful for the clients in understanding the long term prospects of the industry.

The research also reveals that clinical trials in India are mostly conducted in government and private hospitals. On the basis of preliminary enquiries, we have found that there are companies or agencies engaged exclusively in conducting clinical trials in the country. Although the number ICH/GCP compliant sites in India still remain low in comparison to the western countries, it is expected that the number of clinical trials will rise considerably

"Booming Clinical Trials Market in India" is an outcome of extensive research and detailed study of the Indian clinical research industry. In this report, all the important performance indicators of the sector have been discussed in detail. The report also features a comprehensive cost analysis of different phases of clinical trials in India in comparison to other developing and developed countries.

For more information visit: http://www.rncos.com/Report/IM564.htm